채권
아래는 AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 회사채 목록입니다. 투자자들은 시장 변동성이 큰 시기에 안정성을 높이기 위해 회사채를 선택하는 경우가 많습니다. 가격, 수익률 및 기타 통계를 살펴보고 신뢰할 수 있는 투자처를 찾아보세요.
심볼 | YTM % | 거래량 | 가격 % | 쿠폰 % | 머튜어리티 데이트 | 미결제 금액 | 액면가 | 최소 액면 금액 | 발행자 |
|---|---|---|---|---|---|---|---|---|---|
| AA5QBAllergan Funding SCS 4.75% 15-MAR-2045 | 7.55% | 0 | 71.71% | 4.750% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6.53% | 24 K | 82.04% | 4.850% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| WWAPCActavis, Inc. 4.625% 01-OCT-2042 | 6.29% | 0 | 82.80% | 4.625% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
| 6.24% | 0 | 90.21% | 2.625% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS | |
| 5.49% | 26 K | 90.47% | 3.200% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.38% | 0 | 101.86% | 5.500% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.31% | 0 | 101.19% | 5.400% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.30% | 0 | 104.32% | 5.600% | 2055-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5.30% | 22 K | 94.50% | 4.550% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| 5.29% | 0 | 85.83% | 4.250% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.29% | 0 | 94.45% | 4.875% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.26% | 0 | 89.91% | 4.450% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.25% | 0 | 93.33% | 4.700% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.21% | 0 | 101.58% | 5.350% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.20% | 1.45 M | 94.48% | 4.750% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.19% | 315 K | 95.97% | 4.850% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.12% | 0 | 91.81% | 4.400% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.09% | 670 K | 94.77% | 4.625% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.98% | 0 | 90.68% | 4.050% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.66% | 0 | 104.05% | 5.200% | 2035-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.65% | 0 | 97.07% | 4.300% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.60% | 0 | 99.23% | 4.500% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.55% | 1.39 M | 100.02% | 4.550% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.52% | 0 | 103.65% | 5.050% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 4.42% | 0 | 92.48% | 2.125% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
| 4.11% | 0 | 104.01% | 4.950% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.10% | 0 | 103.07% | 4.875% | 2030-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.05% | 0 | 99.55% | 3.200% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.01% | 0 | 96.97% | 3.200% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.00% | 0 | 102.51% | 4.800% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.00% | 0 | 101.09% | 4.800% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.93% | 0 | 98.98% | 2.950% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.89% | 0 | 101.72% | 4.650% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.87% | 0 | 101.07% | 4.250% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.16% | 0 | 126.76% | 4.750% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.13% | 0 | 128.71% | 4.850% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.13% | 0 | 121.31% | 4.250% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 2.81% | 0 | 97.67% | 2.125% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.77% | 0 | 91.61% | 1.250% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.57% | 0 | 123.74% | 4.550% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 2.43% | 0 | 100.58% | 2.625% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.41% | 0 | 99.16% | 2.125% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.28% | 0 | 96.94% | 0.750% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| −5.92% | 0 | 111.17% | 2.950% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| — | — | — | 4.400% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |